Author

Kshyama Subhadarsini Tung

National Institute of Science Education and ResearchORCID 0000-0003-2175-8075Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:human· 1

Frequent Co-Authors

Somlata KhamaruiD· 2 shared Subhasis ChattopadhyayiD· 2 shared Bharat Bhusan SubudhiiD· 1 shared Bijita BhowmickiD· 1 shared Chandan MahishiD· 1 shared Harshit Borasi· 1 shared Kaustuv MukherjeeiD· 1 shared Mahendra GauriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Somlata KhamaruORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neuropilin-1 functions as a proviral and immunoregulatory host factor during Chikungunya virus infection

Kshyama Subhadarsini Tung, Chandan Mahish, Soumyajit Ghosh, Kaustuv Mukherjee, Sharad Singh, Bijita Bhowmick, Somlata Khamaru, Harshit Borasi, Mahendra Gaur, Bharat Bhusan Subudhi, Soma Chattopadhyay, Subhasis Chattopadhyay

This study identifies Neuropilin-1 as a host factor that promotes Chikungunya virus infection while restraining proinflammatory cytokine production, and shows its inhibition reduces viral infection in vitro and in vivo.

bioRxiv · Jul 27, 2026 · PreprintImmunology

Targeting Neuropilin-1 to Enhance Immunotherapy in Melanoma: Reducing Tumour Progression and Peripheral Treg-Mediated Immunosuppression

Somlata Khamaru, Kshyama Subhadarsini Tung, Subhasis Chattopadhyay

This study shows that inhibiting Neuropilin-1 slows B16-F10 melanoma progression and reduces Treg-mediated immunosuppression.

Immunology · Nov 27, 2025Peer-reviewedImmunology